Internal diseases and molecular mechanisms causing slipped capital femoral epiphysis in children

doi:10.5312/wjo.v16.i11.110155

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

This Article

(33)

(46)

(0)

(16)

(731)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Orthopedics

ISSN

2218-5836

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Orthop. Nov 18, 2025; 16(11): 110155
Published online Nov 18, 2025. doi: 10.5312/wjo.v16.i11.110155

Full Size Figure Download Figure

Figure 1 Primary internal diseases associated with slipped capital femoral epiphysis. NF-κB: Nuclear factor kappa B; IGF1: Insulin-like growth factor 1; GH-IGF-1: Growth Hormone-insulin-like growth factor-1 axis; CKD: Chronic kidney disease; MBD: Mineral and bone disorder; SCFE: Slipped capital femoral epiphysis; TSH: Thyroid-stimulating hormone; FSH: Follicle-stimulating hormone; LH: Luteinizing hormone.

Citation: Chen YF, Ning K, Xie YY, Liu C, Ding YT, Tang ZW, Wen J, Xiao S, Li YF. Internal diseases and molecular mechanisms causing slipped capital femoral epiphysis in children. World J Orthop 2025; 16(11): 110155
URL: https://www.wjgnet.com/2218-5836/full/v16/i11/110155.htm
DOI: https://dx.doi.org/10.5312/wjo.v16.i11.110155

Chen YF, Ning K, Xie YY, Liu C, Ding YT, Tang ZW, Wen J, Xiao S, Li YF. Internal diseases and molecular mechanisms causing slipped capital femoral epiphysis in children. World J Orthop 2025; 16(11): 110155 [PMID: 41355829 DOI: 10.5312/wjo.v16.i11.110155]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.